7.1 Respiratory Distress Syndrome (RDS) & Surfactant Deficiency

Respiratory Distress Syndrome (RDS) & Surfactant Deficiency

Respiratory Distress Syndrome (RDS), historically designated hyaline membrane disease, remains the primary cause of acute respiratory failure and neonatal mortality in premature infants. When dispatched to a community hospital or birth center to stabilize and transport a preterm neonate, critical care transport clinicians must possess a deep operational command of surfactant biophysics, non-invasive support strategies, exogenous surfactant administration, and transit mechanical ventilation. Every transport decision balances the need for adequate alveolar recruitment against the profound hazards of ventilator-induced lung injury (VILI), oxygen toxicity, and acute air leak syndromes.

---

Pathophysiology & Biophysical Mechanics of Surfactant Deficiency

Endogenous pulmonary surfactant is a complex lipoprotein network synthesized, packaged, and secreted by type II alveolar pneumocytes. Synthesis begins between 20 and 24 weeks of gestation, but adequate intracellular lamellar body stores and active exocytosis to the alveolar surface are not reliably established until 34 to 36 weeks. Surfactant comprises approximately 80% phospholipids (predominantly dipalmitoylphosphatidylcholine [DPPC]), 10% neutral lipids (primarily cholesterol), and 10% surfactant-specific apoproteins (SP-A, SP-B, SP-C, and SP-D). The small hydrophobic apoproteins SP-B and SP-C are physiologically critical: they promote rapid adsorption, lateral spread, and stabilization of the phospholipid monolayer across the alveolar air-liquid interface.

The Biophysics of Laplace's Law

The fundamental physical behavior of the alveolus is governed by Laplace's Law of Surface Tension for spherical structures:

$$P = \frac{2T}{r}$$

Where:

• $P$ is the collapsing distending pressure required to keep the bubble or alveolus open.
• $T$ is the surface tension at the air-liquid boundary.
• $r$ is the radius of the alveolus.

In the healthy lung, surfactant molecules compress tightly during expiration as alveolar radius ($r$) decreases, dramatically reducing surface tension ($T$) toward near-zero values ($<2\text{ dynes/cm}$). This prevents the distending pressure ($P$) from escalating, ensuring stability across alveoli of varying sizes.

In premature neonates with primary surfactant deficiency, surface tension remains high and static (approximately $70\text{ dynes/cm}$). Consequently, as alveolar radius shrinks during expiration, the collapsing pressure rises exponentially. Smaller alveoli generate substantially higher collapsing pressures than adjacent larger alveoli, causing smaller saccules to collapse into larger ones. This creates diffuse, progressive end-expiratory microatelectasis, massive loss of functional residual capacity (FRC), and profoundly non-compliant, stiff lungs.

Surfactant Deficiency (Prematurity)
       │
       ▼
High Alveolar Surface Tension (Laplace's Law: P = 2T/r)
       │
       ▼
Diffuse End-Expiratory Alveolar Collapse & Microatelectasis
       │
       ▼
Decreased Lung Compliance & Loss of Functional Residual Capacity (FRC)
       │
       ▼
Massive Intrapulmonary Right-to-Left Shunt & Severe V/Q Mismatch
       │
       ▼
Refractory Hypoxemia, Hypercapnia & Mixed Acidosis
       │
       ▼
Pulmonary Vasoconstriction ──► Extrapulmonary Ductal/Atrial Shunting (PPHN)

Physiological Consequences: The Shunt Cascade

The loss of alveolar gas volume generates an intense ventilation-perfusion (V/Q) mismatch. Deoxygenated blood from the pulmonary arterial circulation perfuses non-ventilated, collapsed alveolar units, creating a profound intrapulmonary right-to-left shunt. Alveolar hypoventilation produces progressive hypercapnia, while hypoperfusion and cellular hypoxia induce lactic acidosis. The resulting mixed respiratory and metabolic acidosis triggers intense pulmonary arterial vasoconstriction, raising pulmonary vascular resistance (PVR) and precipitating secondary right-to-left shunting across the patent foramen ovale (PFO) and patent ductus arteriosus (PDA).

---

Clinical Presentation & Diagnostic Evaluation

RDS manifests within the first minutes to hours following delivery, escalating in severity over the first 48 to 72 hours of life if untreated. Clinicians must recognize the classic physical findings of neonatal respiratory distress, each representing a compensatory physiological reflex:

1. Tachypnea (Respiratory Rate > 60 breaths/min): The infant increases respiratory rate to maintain alveolar minute ventilation ($V_E = V_T \times RR$) in the presence of severely compromised tidal volumes dictated by stiff, low-compliance lungs.
2. Expiratory Grunting: The hallmark acoustic sign of neonatal alveolar collapse. The infant exhales against a partially closed glottis, generating 2 to 5 cmH2O of auto-PEEP. This dynamic maneuver increases end-expiratory transpulmonary pressure, arresting progressive alveolar atelectasis and preserving FRC.
3. Nasal Flaring: Active contraction of the anterior dilator naris muscles reduces upper airway resistance by 20% to 30%, decreasing the overall work of breathing.
4. Intercostal, Subcostal, and Sternal Retractions: The neonatal chest wall is highly compliant and predominantly cartilaginous. When stiff, non-compliant lungs generate high negative intrapleural pressures during inspiration, the compliant thoracic cage collapses inward, resulting in prominent retractions and paradoxical 'see-saw' abdominal breathing.
5. Central Cyanosis: Manifests when deoxygenated hemoglobin exceeds 3 to 5 g/dL in arterial blood, reflecting severe intrapulmonary shunting that is refractory to low-flow supplemental oxygen.

Radiographic Hallmarks

Chest radiography is the definitive imaging modality for diagnosing RDS. The classic radiograph demonstrates three cardinal features:

• Reticulogranular Ground-Glass Pattern: Uniform, bilateral, diffuse fine punctate granular opacities produced by widespread microatelectatic alveolar saccules surrounded by aerated alveolar ducts.
• Air Bronchograms: Prominent, dark branching bronchial trees visualized extending into peripheral lung zones, resulting from contrast between air-filled, patent conducting airways and adjacent fluid-filled or collapsed alveoli.
• Bilateral Hypoaeration: Diminished lung volumes characterized by elevated, dome-shaped diaphragms with fewer than 8 posterior ribs visible above the diaphragmatic contour on an inspiratory film.
• Stage 4 'Whiteout': In end-stage or untreated RDS, complete confluent atelectasis obliterates the pulmonary architecture, completely obscuring the cardiac borders and hemidiaphragmatic margins.

---

Respiratory Support Progression: Non-Invasive vs. Invasive Ventilation

Modern neonatal transport stabilization prioritizes non-invasive respiratory support to mitigate ventilator-induced lung injury (VILI). The progression of respiratory support follows clear physiological triggers:

1. Bubble Continuous Positive Airway Pressure (bCPAP)

Bubble CPAP is the gold-standard initial non-invasive modality for spontaneously breathing preterm infants. Delivered via short binasal prongs or an anatomical silicone nasal mask, CPAP maintains continuous positive distending pressure throughout the respiratory cycle.

• Distending Pressure: Standard initial CPAP is set at 5 to 8 cmH2O. Pressures below 5 cmH2O fail to recruit collapsed alveoli, while pressures above 8 cmH2O can overdistend patent terminal bronchioles, increase dead space, impair venous return, and precipitate pneumothorax.
• Stochastic Oscillations: When gas exits an underwater bubble generator, bubbling creates high-frequency pressure oscillations (chest 'wiggle') that propagate down the tracheobronchial tree. These pressure waveforms promote gas mixing via Taylor dispersion, enhance carbon dioxide elimination, and stimulate diaphragmatic activity.

2. Non-Invasive Positive Pressure Ventilation (NIPPV)

NIPPV superimposes time-cycled peak inspiratory pressures (PIP 14–22 cmH2O) over baseline PEEP (5–7 cmH2O) using binasal interfaces. NIPPV increases functional tidal volume, stimulates respiratory drive via pharyngeal stretch receptors, and significantly reduces extubation failure and the need for invasive mechanical ventilation compared to CPAP alone.

3. Indications for Endotracheal Intubation in Transit

While non-invasive support is preferred, transport teams must never delay endotracheal intubation when clear failure criteria emerge before embarking on a ground or air transport:

• Severe Refractory Hypoxemia: Requirement for $\text{FiO}_2 > 0.40$ (or $>0.30$ in infants $<28$ weeks) to maintain target saturation on CPAP $\ge 7-8\text{ cmH}_2\text{O}$.
• Decompensating Respiratory Acidosis: Arterial or capillary $\text{pH} < 7.20$ with $\text{PaCO}_2 > 65\text{ mmHg}$.
• Intractable Apnea: Recurrent apnea requiring bag-mask ventilation, or respiratory exhaustion characterized by progressive bradypnea and severe retractions.
• Hemodynamic Instability: Circulatory shock requiring vasoactive infusions or poor systemic perfusion.

---

Exogenous Surfactant Therapy: Formulations, Criteria & Techniques

Exogenous surfactant replacement fundamentally transforms RDS management by restoring alveolar surface tension, expanding FRC, improving compliance, and resolving intrapulmonary shunting.

Natural Surfactant Formulations

Natural animal-derived surfactants contain SP-B and SP-C, making them vastly superior to early synthetic preparations:

Administration Criteria & Timing

Early surfactant administration—ideally within the first 2 hours of life—yields superior outcomes compared to delayed rescue therapy. Current consensus criteria for surfactant administration in preterm infants include:

• Preterm infant on CPAP $\ge 6\text{ cmH}_2\text{O}$ requiring $\text{FiO}_2 > 0.30$ to maintain target saturation.
• Intubated preterm infant with clinical and radiographic evidence of RDS requiring $\text{FiO}_2 > 0.30$.

Administration Techniques: INSURE vs. LISA/MIST

1. INSURE (INtubate, SURfactant, Extubate): The traditional method. The neonate is intubated, surfactant is instilled via an endotracheal catheter over 1 to 3 minutes, positive pressure breaths are delivered to distribute the drug, and the infant is extubated directly back to CPAP once breathing spontaneously.
2. LISA / MIST (Less / Minimally Invasive Surfactant Administration): While the infant breathes spontaneously on bubble CPAP, direct or video laryngoscopy is performed to visualize the vocal cords. A small-bore vascular catheter (16-gauge angiocatheter or 4–5 Fr feeding tube) is advanced 1 to 2 cm past the vocal cords into the trachea. Surfactant is slowly instilled over 2 to 5 minutes while continuous CPAP remains intact. Spontaneous inspiratory efforts generate negative intrathoracic pressure, drawing surfactant distally into alveolar units without positive-pressure barotrauma.

CRITICAL TRANSPORT PEARL: The Post-Surfactant Compliance Spike

Within 15 to 30 minutes following surfactant instillation, alveolar surface tension drops precipitously, producing an immediate, dramatic surge in pulmonary compliance ($C_L = \Delta V / \Delta P$).

If the transport ventilator is set to pressure-controlled ventilation with a fixed peak inspiratory pressure (PIP), this compliance surge causes delivered tidal volumes to spike uncontrollably from 4 mL/kg to $>8-12\text{ mL/kg}$. Massive volutrauma instantly ruptures fragile terminal saccules, triggering tension pneumothorax, pulmonary interstitial emphysema (PIE), or acute pulmonary hemorrhage.

Transport Rule: The clinician must remain at the bedside post-surfactant, continuously monitoring exhaled tidal volume and chest excursion, and immediately wean PIP and $\text{FiO}_2$ to maintain lung-protective parameters.

Transport Ventilator Management Strategies in Transit

When non-invasive support fails or the infant requires intubation prior to transport, mechanical ventilation must adhere strictly to lung-protective guidelines:

Primary Ventilator Settings

• Ventilation Mode: Volume-targeted ventilation (such as Pressure Support Ventilation with Volume Guarantee [PSV+VG]) is preferred over pure pressure-control ventilation. Volume Guarantee automatically titrates the inspiratory pressure breath-by-breath to deliver a fixed, safe tidal volume regardless of acute changes in pulmonary compliance.
• Target Tidal Volume ($V_T$): 4.0 to 6.0 mL/kg (typically 4.0–5.0 mL/kg in extremely low birth weight infants $<1,000\text{ g}$). Volumes $>6\text{ mL/kg}$ trigger volutrauma and shearing stress; volumes $<3.5\text{ mL/kg}$ cause hypoventilation and microatelectasis.
• Positive End-Expiratory Pressure (PEEP): 5.0 to 7.0 cmH2O. Adequate PEEP prevents end-expiratory alveolar derecruitment and cyclic atelectrauma.
• Inspiratory Time ($T_i$): 0.30 to 0.40 seconds in preterm infants. Because RDS lungs have low compliance and normal airway resistance, the respiratory time constant ($\tau = R \times C$) is extremely short (often $<0.05\text{ seconds}$). An inspiratory time $>0.40\text{ seconds}$ exceeds 3 to 5 time constants, providing no additional alveolar recruitment while promoting air trapping and breath stacking.
• Ventilator Rate: 40 to 60 breaths/min, titrated to maintain permissive hypercapnia.
• Blood Gas Targets: Permissive hypercapnia is standard: target arterial $\text{PaCO}_2$ 45 to 55 mmHg (up to 60 mmHg) with $\text{pH} \ge 7.25$. Avoid aggressive hypocarbia ($\text{PaCO}_2 < 35\text{ mmHg}$), which causes profound cerebral vasoconstriction, periventricular leukomalacia, and neurological impairment.

---

Oxygenation Targets: Avoiding ROP & Hyperoxic Lung Injury

Premature infants possess immature antioxidant enzyme systems (superoxide dismutase, catalase, glutathione peroxidase). Exposure to excessive supplemental oxygen generates toxic reactive oxygen species (ROS), triggering widespread cellular necrosis and endothelial disruption.

• Retinopathy of Prematurity (ROP): Hyperoxia (arterial $\text{PaO}_2 > 80-100\text{ mmHg}$) downregulates vascular endothelial growth factor (VEGF) and erythropoietin in the developing retina, precipitating retinal capillary vaso-obliteration. Subsequent relative hypoxia triggers pathological neovascular proliferation, retinal detachment, and irreversible blindness.
• Bronchopulmonary Dysplasia (BPD): Oxygen free radicals damage the fragile alveolar-capillary membrane, halting secondary alveolar septation and pulmonary microvascular maturation.

Transport Pulse Oximetry Target Protocols

• Preterm Neonates (<32 weeks gestation): Strictly maintain $\text{SpO}_2$ between 90% and 95%.
• Alarm Parameters: Set transport oximeter alarms at about 89% (low) and 95% (high), following unit policy.
• Any saturation reading of $100\text{ \%}$ is an emergency in a preterm infant receiving supplemental oxygen because $\text{PaO}_2$ cannot be determined non-invasively and may exceed 150 to 300 mmHg. Transport clinicians must immediately wean $\text{FiO}_2$ downward whenever $\text{SpO}_2$ exceeds 95%.